Evidence map›Paper›PMID 35476997›Full record

ArticleCell reports2022

Silencing alanine transaminase 2 in diabetic liver attenuates hyperglycemia by reducing gluconeogenesis from amino acids.

Michael R Martino, Manuel Gutiérrez-Aguilar, Nicole K H Yiew, Andrew J Lutkewitte, Jason M Singer, Kyle S McCommis, Daniel Ferguson, Kim H H Liss, Jun Yoshino, M Katie Renkemeyer and 7 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Cell reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
9.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 47 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. FicD sensitizes cellular response to glucose fluctuations in mouse embryonic fibroblasts.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  16. The Role of Mechanistic Biomarkers in Understanding Acetaminophen Hepatotoxicity in Humans.Drug metabolism and disposition: the biological fate of chemicals · 2024
    Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors at 2 institutions in 1 country.

Michael R MartinoDepartment of Medicine, Center for Human Nutrition, Washington University in St. Louis, St. Louis, MO 63110, USA.
Manuel Gutiérrez-AguilarDepartment of Medicine, Center for Human Nutrition, Washington University in St. Louis, St. Louis, MO 63110, USA.
Nicole K H YiewDepartment of Medicine, Center for Human Nutrition, Washington University in St. Louis, St. Louis, MO 63110, USA.
Andrew J LutkewitteDepartment of Medicine, Center for Human Nutrition, Washington University in St. Louis, St. Louis, MO 63110, USA.
Jason M SingerDepartment of Medicine, Center for Human Nutrition, Washington University in St. Louis, St. Louis, MO 63110, USA.
Kyle S McCommisDepartment of Medicine, Center for Human Nutrition, Washington University in St. Louis, St. Louis, MO 63110, USA.
Daniel FergusonDepartment of Medicine, Center for Human Nutrition, Washington University in St. Louis, St. Louis, MO 63110, USA.
Kim H H LissDepartment of Pediatrics, Washington University in St. Louis, St. Louis, MO 63110, USA.
Jun YoshinoDepartment of Medicine, Center for Human Nutrition, Washington University in St. Louis, St. Louis, MO 63110, USA.
M Katie RenkemeyerDepartment of Medicine, Center for Human Nutrition, Washington University in St. Louis, St. Louis, MO 63110, USA.
Gordon I SmithDepartment of Medicine, Center for Human Nutrition, Washington University in St. Louis, St. Louis, MO 63110, USA.
Kevin ChoDepartment of Chemistry, Washington University in St. Louis, St. Louis, MO 63110, USA.
Justin A FletcherCenter for Human Nutrition, University of Texas Southwestern, Dallas, TX 75390, USA.
Samuel KleinDepartment of Medicine, Center for Human Nutrition, Washington University in St. Louis, St. Louis, MO 63110, USA.
Gary J PattiDepartment of Medicine, Center for Human Nutrition, Washington University in St. Louis, St. Louis, MO 63110, USA; Department of Chemistry, Washington University in St. Louis, St. Louis, MO 63110, USA; Siteman Cancer Center, Washington University in St. Louis, St. Louis, MO 63110, USA.
Shawn C BurgessCenter for Human Nutrition, University of Texas Southwestern, Dallas, TX 75390, USA.
Brian N FinckDepartment of Medicine, Center for Human Nutrition, Washington University in St. Louis, St. Louis, MO 63110, USA. Electronic address: bfinck@wustl.edu.
Washington University in St. Louis · USThe University of Texas Southwestern Medical Center · US

Funding

Washington University DDRCC Supplemental Equipment RequestP30DK052574 · NIDDK · WASHINGTON UNIVERSITY · PI Nicholas O. Davidson · 2000 to 2026
$30.8M
Washington University Nutrition Obesity Research CenterP30DK056341 · NIDDK · WASHINGTON UNIVERSITY · PI Dominic N Reeds · 1999 to 2026
$30.2M
WU P&FP30DK020579 · NIDDK · WASHINGTON UNIVERSITY · PI Clay F. Semenkovich · 2013 to 2026
$27.1M
TARGETING THE MITOCHONDRIAL PYRUVATE CARRIER TO TREAT NONALCOHOLIC STEATOHEPATITISR01DK104735 · NIDDK · WASHINGTON UNIVERSITY · PI FINCK, BRIAN N · 2015 to 2025
$7.1M
Factors controlling metabolic flux in the liver - Supplement RevisionR01DK078184 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI Shawn C Burgess · 2008 to 2026
$6.8M
Developing Metabolomic Technologies to Advance Environmental Exposure AnalysisR35ES028365 · NIEHS · WASHINGTON UNIVERSITY · PI PATTI, GARY J · 2017 to 2024
$5.9M
NOVEL ASPECTS OF HEPATIC MITOCHONDRIAL AMINO ACID METABOLISMR01DK117657 · NIDDK · WASHINGTON UNIVERSITY · PI FINCK, BRIAN N · 2018 to 2022
$1.9M
Training in Integrative and Systems Biology of Cardiovascular DiseaseT32HL134635 · NHLBI · WASHINGTON UNIVERSITY · PI NERBONNE, JEANNE M. · 2017 to 2021
$1.8M
Importance and Regulation of Cardiac Mitochondrial Pyruvate TransportR00HL136658 · NHLBI · SAINT LOUIS UNIVERSITY · PI MCCOMMIS, KYLE S · 2019 to 2021
$747k
NHLBI NIH HHS R00 HL136658NHLBI NIH HHS T32 HL134635NIDDK NIH HHS P30 DK020579NIDDK NIH HHS P30 DK052574NIDDK NIH HHS P30 DK056341NIDDK NIH HHS R01 DK078184NIDDK NIH HHS R01 DK104735NIDDK NIH HHS R01 DK117657NIEHS NIH HHS R35 ES028365
6 · The paper itself

Abstract

Hepatic gluconeogenesis from amino acids contributes significantly to diabetic hyperglycemia, but the molecular mechanisms involved are incompletely understood. Alanine transaminases (ALT1 and ALT2) catalyze the interconversion of alanine and pyruvate, which is required for gluconeogenesis from alanine. We find that ALT2 is overexpressed in the liver of diet-induced obese and db/db mice and that the expression of the gene encoding ALT2 (GPT2) is downregulated following bariatric surgery in people with obesity. The increased hepatic expression of Gpt2 in db/db liver is mediated by activating transcription factor 4, an endoplasmic reticulum stress-activated transcription factor. Hepatocyte-specific knockout of Gpt2 attenuates incorporation of

Indexed as

Diabetes MellitusHyperglycemiaAlanineAlanine TransaminaseAmino AcidsAnimalsGluconeogenesisGlucoseHumansLiverMiceMice, Inbred C57BLMice, Inbred StrainsObesityAlanineAlanine TransaminaseAmino AcidsGlucoseamino acidsATF4CP: MetabolismgluconeogenesisGPT2liver

Identifiers

PMID35476997
PMCPMC9121396
OpenAlexW4226060730

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.